🇺🇸 FDA
Pipeline program

BioLexa- Cohort 1

AD-001

Phase 1 small_molecule completed

Quick answer

BioLexa- Cohort 1 for Atopic Dermatitis is a Phase 1 program (small_molecule) at Hoth Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Hoth Therapeutics
Indication
Atopic Dermatitis
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials